Please provide your email address to receive an email when new articles are posted on . High FeNO levels indicate exacerbation and lung function risks. Most patients with high FeNO levels also had ...
Please provide your email address to receive an email when new articles are posted on . The Vivatmo me measures and records fractional exhaled nitric oxide, symptoms and medication use at home. 80.7% ...
This case study has been carried out by Carol Stonham MBE, a Medical Advisory Board member. Carol has worked as a registered nurse since 1986, shifting from acute hospital care to primary care by 1990 ...
Bedfont ® outlines key updates and offers support for healthcare professionals navigating the changes. Bedfont ® Scientific Ltd., world leaders in breath analysis with over 47 years of knowledge in ...
Nov. 17, 2021 – In its latest clinical practice guideline on evaluation and treatment of asthma, an American Thoracic Society expert guidelines panel has addressed the use of fractional exhaled nitric ...
IS LUNG HEALTH DAY, THOUGH MANY OF US TAKE BREATHING FOR GRANTED, MILLIONS OF PEOPLE STRUGGLE GETTING ENOUGH AIR DUE TO ASTHMA CONDITION THAT CAN BE DEADLY. AN ESTIMATED 262 MILLION PEOPLE WORLDWIDE ...
Phase 1b interim results of zumilokibart (APG777) in asthma demonstrated rapid and durable suppression of FeNO (key biomarker of Type 2 inflammation) through 16 weeks for all patients - Suppression of ...
PHOENIX -- Exacerbation-prone asthma patients who had high blood eosinophil counts or elevated fractional exhaled nitric oxide (FeNO) appeared to benefit from lebrikizumab, pooled data from two ...
Multiple doses of APG808 resulted in rapid suppression of FeNO, a biomarker of Type 2 inflammation associated with exacerbations in asthma, with a robust maximal FeNO decrease from baseline of 53% ...
Aerocrine AB announced that Health Care Service Corp. will begin covering FeNO testing for asthma diagnosis and management effective April 1. According to a release, Aerocrine has received ...
Blood eosinophil count and fractional exhaled nitric oxide (FeNO) play an important role in selecting biological therapies for severe asthma. This analysis of patient-level data pooled across 22 ...
Apogee Therapeutics reports early trial data showing its asthma drug APG777 sharply reduced a key inflammation marker for up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback